Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective
Alimentary Pharmacology & Therapeutics · 2025
DOI: 10.1111/apt.18438 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alimentary Pharmacology & Therapeutics, 2025. Verfasst von Yassine Kilani und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College Affiliate, New York, New York, USA. Hauptthemen laut MEDLINE: Vitamin D Deficiency, Hepatitis, Autoimmune. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 72 Literaturangaben.
Abstract (Originalsprache)
Background
Vitamin D deficiency is linked to worse outcomes in patients with chronic liver diseases (CLD). However, data in patients with autoimmune hepatitis (AIH) remain limited.
Aims
We aimed to assess the impact of vitamin D deficiency on the outcomes of individuals with AIH.
Methods
This retrospective cohort study used the TriNetX research network to identify patients with AIH. Patients were matched using propensity score matching and stratified to sufficient vitamin D levels (e.g., 25 (OH) D3 ≥ 30 ng/mL), vitamin D insufficiency (25 (OH) D3: 20–29.9 ng/mL) and vitamin D deficiency (e.g., 25 (OH) D3 < 20 ng/mL). The primary outcome was the all‐cause mortality among adult patients with AIH. Secondary outcomes included decompensated liver cirrhosis, acute hepatic failure, liver transplantation (LT), all‐cause hospitalizations and all‐cause critical care admissions.
Results
A total of 1288 AIH patients with vitamin D deficiency were identified and propensity matched with 1288 patients with normal vitamin D levels. Patients with vitamin D deficiency had significantly increased odds for all‐cause mortality compared to those with normal levels (adjusted odds ratio (aOR) = 3.2, 95%CI: 2.3–4.48). Patients with vitamin D deficiency were at increased odds of all‐cause hospitalizations (aOR = 2.37, 95%CI: 1.97–2.84), critical care unit admissions (aOR = 2.8, 95%CI: 2.21–3.71), decompensated liver cirrhosis (aOR = 2.74, 95%CI: 2.13–3.54), acute hepatic failure (aOR = 3.11, 95%CI: 2.09–4.62) and LT (aOR = 3.47, 95%CI: 1.71–7.04), as compared to those with normal vitamin D levels.
Conclusion
This cohort study showed significantly increased odds for all‐cause mortality in AIH patients with vitamin D deficiency. Vitamin D deficiency in patients with AIH was associated with increased likelihood of hospitalisation, decompensated liver cirrhosis, acute liver failure and LT.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, NYC Health + Hospitals, Lincoln - Weill Cornell Medical College Affiliate, New York, New York, USA.
- Department of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA.
- Division of Gastroenterology & Hepatology, Department of Medicine, Saint Louis University, St. Louis, Missouri, USA.
- Department of Gastroenterology & Hepatology, University of Missouri-Kansas City, Missouri, USA.
- Department of Gastroenterology and Hepatology, Stanford University, Stanford, Palo Alto, USA.
- Department of Physiology, Faculty of Medicine and Nursing, University of Basque Country UPV/EHU, Vizcaya, Spain.
ORCID-Profile: Fouad Jaber
Zitieren
APA
Kilani, Y., Alsakarneh, S., Madi, M. Y., Mosquera, D. A. G., Ferreira, M. N., Jaber, F., Helzberg, J., Duong, N., & Syn, W. K. (2025). Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1111/apt.18438
Vancouver
Kilani Y, Alsakarneh S, Madi MY, Mosquera DAG, Ferreira MN, Jaber F, et al. Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective. Alimentary Pharmacology & Therapeutics. 2025. doi:10.1111/apt.18438
BibTeX
@article{Kilani2025,
author = {Kilani, Yassine and Alsakarneh, Saqr and Madi, Mahmoud Y and Mosquera, Daniel Alejandro Gonzalez and Ferreira, Mariana Nunes and Jaber, Fouad and Helzberg, John and Duong, Nikki and Syn, Wing-Kin},
title = {Autoimmune Hepatitis and Vitamin D Deficiency: A Nationwide Perspective},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2025},
doi = {10.1111/apt.18438}
}
EUVIMED